CX3CL1 and Respiratory tract infection: Compared with other severely ill non-infectious ICU prospectively enrolled patients or healthy volunteers, we observed on average 10 times higher levels of CX3CL1 in the S. aureus respiratory tract infections group in both lung fluids and plasma, respectively (Fig. 1A and B; Tables S1 and S2 ).